Predictive Model of Outcome of Targeted Nodal Assessment in Colorectal Cancer

被引:22
作者
Nissan, Aviram [1 ,3 ]
Protic, Mladjan [1 ,4 ]
Bilchik, Anton [1 ,5 ]
Eberhardt, John [6 ]
Peoples, George E. [1 ,7 ]
Stojadinovic, Alexander [1 ,2 ]
机构
[1] US Mil Canc Inst, Washington, DC USA
[2] Walter Reed Army Med Ctr, Dept Surg, Div Surg Oncol, Washington, DC 20307 USA
[3] Hadassah Hebrew Univ, Med Ctr, Dept Surg, Div Surg Oncol, Jerusalem, Israel
[4] Clin Ctr Vojvodina, Clin Abdominal Endocrine & Transplantat Surg, Novi Sad, Serbia
[5] Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA
[6] DecisionQ Corp, Washington, DC USA
[7] Brooke Army Med Ctr, Dept Surg, Div Surg Oncol, Washington, DC USA
关键词
PROSPECTIVE MULTICENTER TRIAL; RESECTABLE COLON-CANCER; EARLY-STAGE MELANOMA; SENTINEL NODE; BREAST-CANCER; LYMPH-NODES; CARCINOMA; BIOPSY; VIVO; VALIDATION;
D O I
10.1097/SLA.0b013e3181bd5187
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Improvement in staging accuracy is the principal aim of targeted nodal assessment in colorectal carcinoma. Technical factors independently predictive of false negative (FN) sentinel lymph node (SUN) mapping should be identified to facilitate operative decision making. Purpose: To define independent predictors of FN SLN mapping and to develop a predictive model that Could support surgical decisions. Patients and Methods: Data was analyzed from 2 completed prospective clinical trials involving 278 patients with colorectal carcinoma undergoing SLN mapping. Clinical outcome of interest was FN SLN(s),defined as one (s) with no apparent tumor cells in the presence of non-SLN metastases. To assess the independent predictive effect of a covariate for a nominal response (FN SLN), a logistic regression model was constructed and parameters estimated using maximum likelihood. A probabilistic Bayesian model was also trained and cross validated using 10-fold train-and-test sets to predict FN SLN mapping. Area under the curve (AUC) from receiver operating characteristics Curves of these predictions was calculated to determine the predictive value of the model. Results: Number of SLNs (<3; P = 0.03) and tumor-replaced nodes (P < 0.01) independently predicted FN SLN. Cross validation of the model created with Bayesian Network Analysis effectively predicted FN SLN (area under the curve = 0.84-0.86). The positive and negative predictive values of the model are 83% and 97%, respectively. Conclusion: This study supports a minimum threshold of 3 nodes for targeted nodal assessment in colorectal cancer, and establishes sufficient basis to Conclude that SLN mapping and biopsy cannot be justified in the presence of clinically apparent tumor-replaced nodes.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 37 条
  • [21] Validation of sentinel node mapping in patients with colon cancer
    Juan C. Paramo
    Janna Summerall
    Robert Poppiti
    Thomas W. Mesko
    [J]. Annals of Surgical Oncology, 2002, 9 (6) : 550 - 554
  • [22] New data on chemotherapy in the adjuvant setting
    Piccart, MJ
    Sotiriou, C
    Cardoso, F
    [J]. BREAST, 2003, 12 (06) : 373 - 378
  • [23] Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: Results of Cancer and Leukemia Group B trial 80001
    Redston, M
    Compton, CC
    Miedema, BW
    Niedziviecki, D
    Dowell, JM
    Jewell, SD
    Fleshman, JM
    Bem, J
    Mayer, RJ
    Bertagnolli, MM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 878 - 883
  • [24] Sentinel lymph node mapping technique in colon cancer
    Saha, S
    Dan, AG
    Beutler, T
    Wiese, D
    Schochet, E
    Badin, J
    Branigan, T
    Ng, P
    Bassily, N
    David, D
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (03) : 374 - 381
  • [25] Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: A prospective trial
    Saha, S
    Monson, KM
    Bilchik, A
    Beutler, T
    Dan, AG
    Schochet, E
    Wiese, D
    Kaushal, S
    Ganatra, B
    Desai, D
    [J]. DISEASES OF THE COLON & RECTUM, 2004, 47 (11) : 1767 - 1772
  • [26] Saha S, 2005, CANC TREAT, P105
  • [27] Lymphoscintigraphic localization of sentinel node in early colorectal cancer:: Results of a monocentric study
    Sandrucci, Sergio
    Mussa, Baudolino
    Goss, Matteo
    Mistrangelo, Massimiliano
    Satolli, Maria Antonietta
    Sapino, Anna
    Bello, Marilena
    Bisi, Gianni
    Mussa, Antonio
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (06) : 464 - 469
  • [28] Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality
    Schneider, EC
    Epstein, AM
    Malin, JL
    Kahn, KL
    Emanuel, EJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 2985 - 2991
  • [29] Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data
    Shen, RL
    Ghosh, D
    Chinnaiyan, AM
    [J]. BMC GENOMICS, 2004, 5 (1)
  • [30] Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
    Smith, Jenni
    Hwang, Hamish
    Wiseman, Kevin W.
    Filipenko, Douglas
    Phang, P. Terry
    [J]. AMERICAN JOURNAL OF SURGERY, 2006, 191 (05) : 665 - 668